Stockreport

I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024 [Yahoo! Finance]

I-MAB - American Depositary Shares  (IMAB) 
PDF ROCKVILLE, Md. Sept. 16, 2024 Barcelona , Spain. Givastomig (TJ033721 / ABL111) is a bispecific antibody targeting Claudin 18.2-positive tumor cells that conditionall [Read more]